INDUSTRY NEWS

Aramco’s Prosperity7 Ventures Leads Series D+ for China’s Insilico Medicine; Series D Rounds Total USD95m

Source(s): Globe Newswire (Insilico Medicine) | PR Newswire (Insilico Medicine)

Prosperity7 Ventures, the diversified growth fund of Aramco, led a Series D extension for Insilico Medicine, a China-based clinical-stage AI drug company, bringing the total Series D funding to USD95m. Read more here and here